Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

  • ID: 3513254
  • Company Profile
  • 122 pages
  • Global Markets Direct
1 of 4
Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Summary

The report ‘Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Ono Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ono Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Ono Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Ono Pharmaceutical Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Ono Pharmaceutical Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Ono Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Ono Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Ono Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Ono Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ono Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Ono Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Ono Pharmaceutical Co., Ltd. Snapshot

Ono Pharmaceutical Co., Ltd. Overview

Key Information

Key Facts

Ono Pharmaceutical Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

Ono Pharmaceutical Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Pipeline Products Glance

Ono Pharmaceutical Co., Ltd. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Ono Pharmaceutical Co., Ltd. - Drug Profiles

carfilzomib

Product Description

Mechanism of Action

R&D Progress

nivolumab

Product Description

Mechanism of Action

R&D Progress

abatacept

Product Description

Mechanism of Action

R&D Progress

aprepitant

Product Description

Mechanism of Action

R&D Progress

etelcalcetide

Product Description

Mechanism of Action

R&D Progress

ivabradine hydrochloride

Product Description

Mechanism of Action

R&D Progress

anamorelin hydrochloride

Product Description

Mechanism of Action

R&D Progress

gemilukast

Product Description

Mechanism of Action

R&D Progress

ONO-2952

Product Description

Mechanism of Action

R&D Progress

ONO-9054

Product Description

Mechanism of Action

R&D Progress

metyrosine

Product Description

Mechanism of Action

R&D Progress

(levodopa prodrug + carbidopa)

Product Description

Mechanism of Action

R&D Progress

ONO-1266

Product Description

Mechanism of Action

R&D Progress

ONO-4059

Product Description

Mechanism of Action

R&D Progress

ONO-4232

Product Description

Mechanism of Action

R&D Progress

ONO-4474

Product Description

Mechanism of Action

R&D Progress

ONO-7268MX1

Product Description

Mechanism of Action

R&D Progress

ONO-7268MX2

Product Description

Mechanism of Action

R&D Progress

ONO-8055

Product Description

Mechanism of Action

R&D Progress

opicapone

Product Description

Mechanism of Action

R&D Progress

salirasib

Product Description

Mechanism of Action

R&D Progress

E-0001163

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Autoimmune Disease

Product Description

Mechanism of Action

R&D Progress

ONO-4310321

Product Description

Mechanism of Action

R&D Progress

ONO-8430506

Product Description

Mechanism of Action

R&D Progress

oprozomib

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Protease Enzyme for Undisclosed Indication

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Antagonize S1P2 for Liver Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Antagonize GPCR for Undisclosed Indication

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Target Ion-Channels for Cardiovascular, Central Nervous System and Urological Diseases

Product Description

Mechanism of Action

R&D Progress

Ono Pharmaceutical Co., Ltd. - Pipeline Analysis

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Target

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action

Ono Pharmaceutical Co., Ltd. - Recent Pipeline Updates

Ono Pharmaceutical Co., Ltd. - Dormant Projects

Ono Pharmaceutical Co., Ltd. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

arundic acid

asimadoline

ceralifimod

freselestat

methylnaltrexone bromide

ONO-2506-PO

ONO-4053

ONO-4127

ONO-5129

ONO-5334

ONO-6126

ONO-8539

remimazolam

rivenprost

tecemotide

Ono Pharmaceutical Co., Ltd. - Company Statement

Ono Pharmaceutical Co., Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Ono Pharmaceutical Co., Ltd., Key Information

Ono Pharmaceutical Co., Ltd., Key Facts

Ono Pharmaceutical Co., Ltd. - Pipeline by Indication, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015

Ono Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015

Ono Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2015

Ono Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015

Ono Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015

Ono Pharmaceutical Co., Ltd. - Pre-Registration, 2015

Ono Pharmaceutical Co., Ltd. - Phase III, 2015

Ono Pharmaceutical Co., Ltd. - Phase II, 2015

Ono Pharmaceutical Co., Ltd. - Phase I, 2015

Ono Pharmaceutical Co., Ltd. - Preclinical, 2015

Ono Pharmaceutical Co., Ltd. - Discovery, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Target, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2015

Ono Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2015

Ono Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2015

Ono Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2015

Ono Pharmaceutical Co., Ltd., Other Locations

Ono Pharmaceutical Co., Ltd., Subsidiaries

List of Figures

Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015

Ono Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015

Ono Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015

Ono Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll